On July 18, 2011, Galderma Laboratories filed a patent infringement lawsuit against Tolmar in the Northern District of Texas. According to the Complaint (available here), Tolmar manufactures a generic 1% metronidazole topical gel for use in the treatment of rosacea, which it has filed an Abbreviated New Drug Application with the FDA for. Galderma claims that this gel infringes its U.S. Patent No. 7,981,916, which claims technology relating to solubilizing metronidazole.
Galderma is represented by Michael Wilson and Jamil Alibhai, both of Munck Carter, LLP; and by Joseph Mahoney, Vera Nackovic, Melissa Anyetei, and Erick Palmer, all of Mayer Brown LLP.
The case is before Judge Solis.